Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver

被引:86
作者
Hanioka, N [1 ]
Jinno, H [1 ]
Nishimura, T [1 ]
Ando, M [1 ]
机构
[1] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan
关键词
bisphenol A; cytochrome P450; cytochrome P450 isoforms; rat liver microsomes; endocrine disrupter;
D O I
10.1007/s002040050518
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We examined the effect of bisphenol A (BPA) on microsomal cytochrome P450 (P450) enzymes in rats. Rats were treated intraperitoneally with BPA daily for 4 days, at doses of 10, 20, and 40 mg/kg. Among the P450-dependent monooxygenase activities, testosterone 2 alpha-hydroxylase (T2AH) and testosterone 6 beta-hydroxylase (T6BH) activities, which are associated with CYP2C11 and CYP3A2 respectively, were remarkably decreased by 40 mg/kg BPA. The levels of the control activities were 13 and 50%, respectively. Furthermore, immunoblotting showed that BPA (20 or 40 mg/kg) significantly reduced CYP2C11/6 and CYP3A2/1 protein levels in rat liver microsomes. In addition, estradiol 2-hydroxylase (ED2H) and benzphetamine N-demethylase (BZND) activities were significantly decreased by BPA at 20 and 40 mg/kg (by 19-73%). The K-m values for T2AH and T6BH in 20 and 40 mg/kg BPA-treated rats were significantly high compared with that in control rats. The V-max for T2AH was dose-dependently decreased by BPA treatment, whereas that of T6BH was only decreased by BPA at 40 mg/kg. On the other hand, lauric acid omega-hydroxylase (LAOH) activity was significantly increased by BPA at 20 and 40 mg/kg (1.5- and 1.7-fold, respectively). Immunoblot analysis showed that 20 and 40 mg/kg BPA induced CYP4A1/2 protein expression. However, the activities 7-ethoxyresorufin O-deethylase (EROD), 7-methoxyresorufin O-demethylase (MROD), 7-ethoxycoumarin O-deethylase (ECOD), 7-benzyloxyresorufin O-debenzylase (BROD), aminopyrine N-demethylase (APND), chlorzoxazone 6-hydroxylase (CZ6H), erythromycin N-demethylase (EMND), and testosterone 7 alpha-hydroxylase (T7AH) were not affected by BPA at any dose. These results suggest that BPA affects male-specific P450 isoforms in rat liver, and that these changes closely relate to the toxicity of BPA.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 48 条
[1]   SIMPLE AND SENSITIVE ASSAY OF 7-ETHOXYCOUMARIN DEETHYLATION [J].
AITIO, A .
ANALYTICAL BIOCHEMISTRY, 1978, 85 (02) :488-491
[2]   BISPHENOL-A - ACUTE AQUATIC TOXICITY [J].
ALEXANDER, HC ;
DILL, DC ;
SMITH, LW ;
GUINEY, PD ;
DORN, P .
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 1988, 7 (01) :19-26
[3]   ESTRADIOL METABOLISM BY COMPLEMENTARY DEOXYRIBONUCLEIC ACID-EXPRESSED HUMAN CYTOCHROME-P450S [J].
AOYAMA, T ;
KORZEKWA, K ;
NAGATA, K ;
GILLETTE, J ;
GELBOIN, HV ;
GONZALEZ, FJ .
ENDOCRINOLOGY, 1990, 126 (06) :3101-3106
[4]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHY METHODS FOR SEPARATION OF OMEGA-HYDROXY AND (OMEGA-1)-HYDROXY FATTY-ACIDS - THEIR APPLICATIONS TO MICROSOMAL FATTY-ACID OMEGA-OXIDATION [J].
AOYAMA, T ;
SATO, R .
ANALYTICAL BIOCHEMISTRY, 1988, 170 (01) :73-82
[5]   CHEMICAL-STRUCTURE, SALMONELLA MUTAGENICITY AND EXTENT OF CARCINOGENICITY AS INDICATORS OF GENOTOXIC CARCINOGENESIS AMONG 222 CHEMICALS TESTED IN RODENTS BY THE UNITED-STATES NCI/NTP [J].
ASHBY, J ;
TENNANT, RW .
MUTATION RESEARCH, 1988, 204 (01) :17-115
[6]   IN-VIVO DNA ADDUCT FORMATION BY BISPHENOL-A [J].
ATKINSON, A ;
ROY, D .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1995, 26 (01) :60-66
[7]   IN-VITRO CONVERSION OF ENVIRONMENTAL ESTROGENIC CHEMICAL BISPHENOL-A TO DNA-BINDING METABOLITE(S) [J].
ATKINSON, A ;
ROY, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (02) :424-433
[8]   STUDIES ON INVIVO AND INVITRO ESTROGENIC ACTIVITIES OF METHOXYCHLOR AND ITS METABOLITES ROLE OF HEPATIC MONO-OXYGENASE IN METHOXYCHLOR ACTIVATION [J].
BULGER, WH ;
MUCCITELLI, RM ;
KUPFER, D .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (20) :2417-2423
[9]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[10]  
CASTLE PJ, 1995, DRUG METAB DISPOS, V23, P1037